SenesTech, Inc. (SNES) stock: key figures, P/E, revenue and dividend
Materials · United States · ISIN US81720R6045
SenesTech, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 2.22 m USD |
| Gross profit | 1.39 m USD |
| Operating income | -6.51 m USD |
| EBIT | -6.36 m USD |
| Net income | -6.38 m USD |
| Diluted EPS – continuing operations | -1.95 USD |
Full history since 2014, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SenesTech, Inc.
SenesTech, Inc. engages in the development and commercialization of a technology for managing animal pest populations through fertility control. The company offers ContraPest, a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide and triptolide; and Evolve, a soft bait containing the active ingredient, cottonseed oil that limits the reproduction of male and female rats beginning with the first breeding cycles following consumption. It also develops Evolve Mouse, a modified version of its bait technology containing the active ingredient cottonseed oil that limits reproduction of male and female mice. The company was incorporated in 2004 and is headquartered in Surprise, Arizona.
More stocks
- King Resources, Inc. (KRFG)
- Trillion Energy International Inc. (TRLEF)
- reAlpha Tech Corp. (AIRE)
- Yellowstone Group Ltd. (YSGL)
- Bluejay Diagnostics, Inc. (BJDX)
- Power REIT (PW)
- HealthLynked Corp (HLYK)
- VivoSim Labs, INC. (VIVS)
- OFA Group (OFAL)
- KALA BIO, Inc. (KALA)
- Quantum Genesis AI Corp. (QGAI)
- My City Builders, Inc. (MYCB)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.